EP3609497 - Bibliographic data
NIRAPARIB, ACÉTATE D'ABIRATÉRONE ET PREDNISONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE
| Last update | 08/06/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Janssen Pharmaceutica NV Turnhoutseweg 30
2340 Beerse
Belgique
|
|---|---|
| (72) Inventors |
Margaret K. YU 10990 Wilshire Blvd., Suite 300
Los Angeles, California 90024
États-Unis d'Amérique
Linda Anne SNYDER 1400 McKean Road
Spring House, Pennsylvania 19477
États-Unis d'Amérique
|
| (74) Agent |
Mail recipient Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
Royaume-Uni
|
| (21) Request number | EP18720895.4 |
|---|---|
| (22) Request date | 09/04/2018 |
| (11) Publication number | EP3609497 |
|---|---|
| Publication date | 12/10/2022 |
| (54) Title of the invention | NIRAPARIB, ACÉTATE D'ABIRATÉRONE ET PREDNISONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE |
|---|---|
| (51) International classification | A61K 31/454, A61K 31/573, A61K 31/58, A61P 35/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 201762485164 P |
|---|---|
| Initial application | None |
| Divisional application | EP22200801.3 /EP4176878EP22200882.3 /EP4176879 None |
| Expected annuity | Annuity: 9 - Amount: 175 € - Due date 30/04/2026 |
|---|---|
| Last annuity | Annuity: 8 - Payment date 27/03/2025 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 12/10/2022 |